These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 28867159)
1. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma. Taïeb D; Pacak K Trends Endocrinol Metab; 2017 Nov; 28(11):807-817. PubMed ID: 28867159 [TBL] [Abstract][Full Text] [Related]
2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related]
3. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990 [TBL] [Abstract][Full Text] [Related]
4. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas. Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547 [TBL] [Abstract][Full Text] [Related]
5. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Timmers HJ; Taieb D; Pacak K Horm Metab Res; 2012 May; 44(5):367-72. PubMed ID: 22399235 [TBL] [Abstract][Full Text] [Related]
6. Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups. Taïeb D; Jha A; Treglia G; Pacak K Endocr Relat Cancer; 2019 Nov; 26(11):R627-R652. PubMed ID: 31561209 [TBL] [Abstract][Full Text] [Related]
7. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma. Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526 [TBL] [Abstract][Full Text] [Related]
8. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658 [TBL] [Abstract][Full Text] [Related]
9. Pheochromocytomas and paragangliomas. Yen K; Lodish M Curr Opin Pediatr; 2021 Aug; 33(4):430-435. PubMed ID: 34039901 [TBL] [Abstract][Full Text] [Related]
10. Performance of Han S; Suh CH; Woo S; Kim YJ; Lee JJ J Nucl Med; 2019 Mar; 60(3):369-376. PubMed ID: 30030341 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas. Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085 [TBL] [Abstract][Full Text] [Related]
12. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Crona J; Taïeb D; Pacak K Endocr Rev; 2017 Dec; 38(6):489-515. PubMed ID: 28938417 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World. Patel M; Tena I; Jha A; Taieb D; Pacak K Front Endocrinol (Lausanne); 2021; 12():625312. PubMed ID: 33854479 [TBL] [Abstract][Full Text] [Related]
14. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma. van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884 [TBL] [Abstract][Full Text] [Related]
15. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study. Xu S; Pan Y; Zhou J; Ju H; Zhang Y Clin Nucl Med; 2022 Apr; 47(4):299-304. PubMed ID: 35143455 [TBL] [Abstract][Full Text] [Related]
16. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE. Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820 [TBL] [Abstract][Full Text] [Related]
17. Kan Y; Zhang S; Wang W; Liu J; Yang J; Wang Z Acta Radiol; 2018 Dec; 59(12):1466-1474. PubMed ID: 29566550 [TBL] [Abstract][Full Text] [Related]